News
Novavax Stock Soars on FDA Approval for COVID Vaccine
In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with 57,000 calls and 13,000 puts exchanged so far. The weekly 5/23 9-strike call is the most active, with new positions opening there.
The Food and Drug Administration will soon “unleash a massive framework” for how vaccines are tested and approved.
The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do ...
Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.
The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to ...
Mexico halts Brazilian poultry imports after a bird flu outbreak, the U.S. FDA conditionally approves Novavax's COVID vaccine ...
Novavax (NasdaqGS:NVAX) recently reported a significant financial turnaround for Q1 2025, demonstrating substantial revenue growth and net income improvements. The amending of its collaboration ...
Novavax shares jumped 16.6% to $7.84 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Markets expect rate cuts — but your earnings don’t have to suffer. Lock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback